Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U4atac small nuclear 16, pseudogene (RNU4ATAC16P) is a non-coding RNA pseudogene annotated in the human genome[1][5]. It is homologous to the functional RNU4ATAC gene, which encodes the U4atac snRNA, a core component of the minor (U12-dependent) spliceosome complex involved in splicing a small subset of pre-mRNA introns[6]. However, as a pseudogene, RNU4ATAC16P lacks known coding potential and established direct biological or clinical function, and is not considered a therapeutic target. Pseudogenes such as RNU4ATAC16P may sometimes have regulatory roles through RNA-based mechanisms, but specific roles for this pseudogene are not described in current sources[3]. There are no known drug interactions, disease associations, or reported biomarker or safety concerns for RNU4ATAC16P. Its functional parent gene (RNU4ATAC, not the pseudogene) is associated with rare recessive developmental syndromes, but this does not extend to the pseudogene itself[2][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U4atac small nuclear 16, pseudogene (RNU4ATAC16P).